These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3086232)

  • 1. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.
    Spitznagel JK; Goodrum KJ; Warejcka DJ; Weaver JL; Miller HL; Babcock L
    Infect Immun; 1986 Jun; 52(3):803-11. PubMed ID: 3086232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.
    Greenblatt J; Boackle RJ; Schwab JH
    Infect Immun; 1978 Jan; 19(1):296-303. PubMed ID: 415005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
    Baker JJ; Billy SA
    Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.
    Tauber JW; Polley MJ; Zabriskie JB
    J Exp Med; 1976 Jun; 143(6):1352-66. PubMed ID: 818335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis and protoplast formation of group B streptococci by mutanolysin.
    Calandra GB; Cole RM
    Infect Immun; 1980 Jun; 28(3):1033-7. PubMed ID: 6995317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.
    Janusz MJ; Eisenberg RA; Schwab JH
    Inflammation; 1987 Mar; 11(1):73-85. PubMed ID: 3552978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternate complement pathway activation by group A streptococci: role of M-protein.
    Bisno AL
    Infect Immun; 1979 Dec; 26(3):1172-6. PubMed ID: 118929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the susceptibility of inbred and outbred rats to arthritis induced by cell walls of group A streptococci.
    Anderle SK; Greenblatt JJ; Cromartie WJ; Clark R; Schwab JH
    Infect Immun; 1979 Aug; 25(2):484-90. PubMed ID: 385498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Localization of group A streptococcal nontype-specific antigens and their occurrence among streptococci of different groups].
    Bukhova VP; Borodiiuk NA; Kolesnikova VIu; Akimova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jan; (1):75-9. PubMed ID: 106600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.
    Eisenberg RA; Schwab JH
    Infect Immun; 1986 Aug; 53(2):324-30. PubMed ID: 3089935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.
    Lambris JD; Allen JB; Schwab JH
    Infect Immun; 1982 Jan; 35(1):377-80. PubMed ID: 7033141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement resistance mechanisms of streptococci.
    Jarva H; Jokiranta TS; Würzner R; Meri S
    Mol Immunol; 2003 Sep; 40(2-4):95-107. PubMed ID: 12914816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro.
    Smialowicz RJ; Schwab JH
    Infect Immun; 1977 Sep; 17(3):591-8. PubMed ID: 409678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci.
    Bender A; Kabelitz D
    Clin Exp Immunol; 1992 Aug; 89(2):301-4. PubMed ID: 1386299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.
    Spitznagel JK; Goodrum KJ; Warejcka DJ
    Am J Pathol; 1983 Jul; 112(1):37-47. PubMed ID: 6407330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.
    Stimpson SA; Lerch RA; Cleland DR; Yarnall DP; Clark RL; Cromartie WJ; Schwab JH
    Infect Immun; 1987 Jan; 55(1):16-23. PubMed ID: 3539800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats.
    Lehman TJ; Allen JB; Plotz PH; Wilder RL
    Rheumatol Int; 1985; 5(4):163-7. PubMed ID: 3931201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls.
    Schwab JH; Allen JB; Anderle SK; Dalldorf F; Eisenberg R; Cromartie WJ
    Immunology; 1982 May; 46(1):83-8. PubMed ID: 7042551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of bacterial cell wall polymers and rat macrophages.
    Schwab JH; Smialowicz R
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):283-8. PubMed ID: 126561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.